New Products as presented in the January 2002 issue of Urology Times
Unfortunately, infection associated with placement of a penile prosthesis is infrequent, occurring in about 1% to 3% of cases. In the past, this was a catastrophic occurrence that necessitated the removal of the implant and a later return for replacement, if the patient wished.
Chicago-A mixed serotonin and noradrenaline reuptake inhibitor appears to reduce the symptoms associated with stress urinary incontinence (SUI) and improve the quality of life in patients receiving it, according to findings from a phase II clinical trial presented at the American Urogynecologic Society 22nd annual scientific meeting here. While the agent, duloxetine, is still investigational, observers say the prospects for a pharmacologic approach to stress incontinence are promising.
New York-Treatment with oral desmopressin significantly reduces the rate
of nocturnal voiding episodes in men with nocturia, results of a placebo-controlled
trial suggest. One-third of men treated with desmopressin (DDAVP) had at least a 50%
reduction in nighttime voiding compared with 3% of placebo-treated patients
after 3 weeks.
New York-Recently published data could better help diagnose and select treatments for infertile couples, targeting treatments likely to work and perhaps sparing some patients invasive, high-cost treatments less likely to prove effective.
Patients with metastatic renal cell cancer historically have had a poor
prognosis, and attempts with hormonal therapy and chemotherapy have had
disappointing results. In this exclusive Urology Times interview, W. Marston
Linehan, MD, discusses new treatment strategies for renal cell carcinoma,
including multimodality therapy with surgery and systemic therapy, and adoptive
immunotherapy. Dr. Linehan is chief of urologic surgery at the National
Cancer Institute, Bethesda, MD. UT Editorial Consultant Andrew C. Novick,
MD, chairman of the Cleveland Clinic Urological Institute, conducted the
Washington-While several major health issues that were sidetracked
by the Sept. 11 terrorist attacks are poised for consideration by Congress
when it returns to action this month, lobbyists for urologists and other
physician groups were working hard at press time to prevent a reduction
in 2002 Medicare fees.
According to the Internal Revenue Service, failure to file tax returns
and fraud are increasing. At the same time, the number of tax returns examined
has declined dramatically in recent years. So why worry about documenting
the expenses of your urology practice?
It's time to add electronic medical records, or EMR, to the list of buzzwords
common in medical practices today. This new technology, although in its
infancy, has the opportunity to facilitate many of the goals common to all
practices-efficiency, correct coding, Medicare and HIPAA compliance, and
improved outcomes. We are in a new age of medicine, and EMR technology will
transform the way you practice.
Q Can you please clarify the tax ramifications associated with long-term